GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inventage Lab Inc (XKRX:389470) » Definitions » ROE % Adjusted to Book Value

Inventage Lab (XKRX:389470) ROE % Adjusted to Book Value : 11.63% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Inventage Lab ROE % Adjusted to Book Value?

Inventage Lab's ROE % for the quarter that ended in Mar. 2024 was 169.80%. Inventage Lab's PB Ratio for the quarter that ended in Mar. 2024 was 14.60. Inventage Lab's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 11.63%.


Inventage Lab ROE % Adjusted to Book Value Historical Data

The historical data trend for Inventage Lab's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inventage Lab ROE % Adjusted to Book Value Chart

Inventage Lab Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
- - - -13.89 -4.65

Inventage Lab Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.02 -26.76 -6.62 9.36 11.63

Competitive Comparison of Inventage Lab's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Inventage Lab's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inventage Lab's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Inventage Lab's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Inventage Lab's ROE % Adjusted to Book Value falls into.



Inventage Lab ROE % Adjusted to Book Value Calculation

Inventage Lab's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-154.94% / 33.35
=-4.65%

Inventage Lab's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=169.80% / 14.60
=11.63%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Inventage Lab ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Inventage Lab's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Inventage Lab (XKRX:389470) Business Description

Traded in Other Exchanges
N/A
Address
24, Dunchon-daero 388 beon-gil, 612, Woolim Lions Valley 3, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 13403
Inventage Lab Inc operates medical technology development businesses. It engages in the development of an innovative Drug Delivery System (DDS). It has developed Laminar FluiDigm, a microfluidics-based novel platform technology that builds the foundation for IVL- DrugFluidic and IVL-GeneFluidic, which are specific platform technologies used for developing and manufacturing long-acting injectables and gene-delivery therapeutics.

Inventage Lab (XKRX:389470) Headlines

No Headlines